Rationale Although widely prescribed, little is known about the effects of selective serotonin reuptake inhibitors (SSRIs) on social behavior and cerebrospinal fluid (CSF) monoamines in female primates. Objective The objective of this study was to determine the effects of sertraline on agonistic and affiliative behavior. Methods Twenty-one adult female cynomolgus monkeys were housed in small, stable social groups, trained to participate in oral dosing, and began a 5-week cumulative dose-response study. Serial doses of 0, 5, 10, 15, and 20 mg/kg of sertraline were administered orally for 1 week each. Behavior was recorded daily during 10-min observations before and 4 h after dosing. On the seventh day of dosing, circulating sertraline/desmethylsertraline and CSF monoamines/metabolites were determined 4 h after the last dose. Results At 20 mg/kg, circulating sertraline/desmethylsertraline was in the therapeutic range. CSF 5-hydroxyindole acetic acid decreased by 33 % (p <0.05). Overall aggression, submission, locomotion, and time alone decreased, whereas affiliative behaviors (body contact, grooming) increased (all p values <0.05). Effects of sertraline on aggression and submission were social status-dependent, reducing aggression in dominants and submission in subordinates. Conclusions A clinically relevant oral dose of sertraline resulted in CSF metabolite changes similar to those observed in patients and altered the socioemotional behavior of female monkeys. Changes in CSF 5-HT and dopamine are novel observations that may be sex-specific. The robust effects of sertraline on aggression and affiliation may explain the efficacy of SSRIs on a range of human behavioral pathologies that share the characteristics of increased aggression and decreased sociality.
Introduction
Data from the National Health and Nutrition Examination Survey [2005] [2006] [2007] [2008] suggest that antidepressants are the third most common prescription drug taken by Americans of all ages and the most frequently used by persons aged 18-44 years. About 1 in 10 Americans aged 12 years and over take antidepressant medication. Women are 2.5 times more likely than men to take antidepressants and 23 % of women aged 40-59 take antidepressants. More than 60 % of Americans taking antidepressant medication have taken it for 2 years or longer, 14 % having taken the medication for 10 years or more. Less than one-third of Americans taking one antidepressant medication and less than one-half of those taking multiple antidepressants have seen a mental health professional in the past year (Pratt et al. 2011) . Side effects are common including sexual dysfunction (Segraves 2007) . A selective serotonin reuptake inhibitor (SSRI)-induced apathy syndrome has been identified (Barnhart et al. 2004) , and discontinuation of treatment can be difficult and uncomfortable and is referred to as the SSRI discontinuation syndrome (Schatzberg et al. 2006) . Anderson and colleagues (2005) used sertraline to study the time course of the drug's biological activity in the context of the commonly reported, though questioned (Taylor et al. 2006) , time lag for the clinical effects of the SSRIs. Few primate studies have assessed sertraline effects on social behavior; however, one study examining treatments for type 2 alcoholism showed that sertraline reduces alcohol intake and at the same time reduces aggression (Higley et al. 1998 ). Other SSRIs have been evaluated for self-injurious and stereotypic behavior in nonhuman primates (Fontenot et al. 2009 ). Given sertraline's level of use and its side effects, as well as the known involvement of the central 5-HT system in most major classes of behavior, it is surprising that studies of the effects of SSRIs on broad classes of social behavior in animal models, and particularly primate models, are not available.
Here, we report the effects of a commonly prescribed SSRI, sertraline HCl (Zoloft ®), on the agonistic and affiliative behavior of socially housed adult female cynomolgus monkeys (Macaca fascicularis).
Methods

Subjects
Twenty-two adult, reproductive-aged female cynomolgus monkeys were imported directly from Indonesia (Institut Pertanian Bogor, Bogor, Indonesia) and quarantined in single cages for 1 month. Following quarantine, the monkeys were housed in social groups (n =4-5), in indoor pens (3.05 m× 3.05 m×3.05 m), in a climate-controlled building, with 12/12 light/dark and water ad libitum. All monkeys were fed a Western-like diet containing 44 % of calories from fat and 0.29 mg/cal cholesterol, approximately equal to a human consumption of 500 mg cholesterol/2,000 cal (Table 1) . One animal had an adverse reaction (hemorrhaging) to the sertraline and was removed from treatment, leaving a final sample size of 21. The incidence of bleeding in one animal is consistent with increased risk of bleeding in patients treated with sertraline (Andrade et al. 2010 ).
Experimental design
Eighteen months following formation of social groups, the monkeys were trained to run out of their social group pens into a dosing cage where they were individually offered fat-free vanilla pudding orally from a metal syringe. After consuming the pudding orally, the monkeys were immediately released into their home cage. This initial dose training was completed in about 2 weeks, and a cumulative dose-response study of sertraline HCl (Zoloft®) was initiated. Doses of 0, 5, 10, 15, and 20 mg/kg were administered orally in the pudding for 1 week each at about 0800 hours each day. On day 7 of each dose and 4 h after dosing, the monkeys were sedated with 10-15 mg/kg ketamine HCl and blood samples were taken to measure plasma levels of sertraline and desmethylsertraline. In addition, cerebrospinal fluid (CSF) samples were taken every 2 weeks at the 0-, 10-, and 20-mg/kg doses for the determination of 5-hydroxy indole acetic acid (5-HIAA, a metabolite of 5-HT) concentrations. CSF samples were taken by inserting a 22-gauge needle percutaneously into the cisternal space while the ketamine-sedated animal was maintained in a lateral recumbent position. Approximately 1-1.5 cm 3 of spinal fluid was obtained and frozen at −70°C until metabolite determinations were made.
Assays
Sertraline and desmethylsertraline were analyzed by gas chromatography (NMS Labs, Willow Grove, PA). An internal standard (8-chloroperphenazine) was added to 1.0-ml serum aliquots that were buffered to pH 10 and extracted with toluene and back-extracted into dilute H 2 SO 4 . The acid was made basic and extracted with toluene. Sertraline and metabolite were derivatized with butyric anhydride and analyzed on a DB-5 capillary column, using an Agilent 6890 Gas Chromatograph with nitrogen-selective detection. This GC/NPD method was calibrated over a range of 1 to 200 ng/mL, with interassay precision for sertraline/desmethylsertraline of 14/22 and 10/14 % at 10 and 140 ng/mL, respectively. Elution times were approximately 7.2 and 6.9 min for sertraline and desmethylsertraline, respectively. 5-HIAA was analyzed using high-pressure liquid chromatography (HPLC) with electrochemical detection as previously described (Shively et al. 2007 ). Intra-and interassay coefficients of variation were <10 %.
Behavior observations
Seven behaviors (aggression, submission, locomotion, passive body contact, grooming, being groomed, and alone) were recorded at 20-s intervals, in 10-min group scans, 6 days/ week, twice/day: once in the morning prior to the daily dose at approximately 0800 hours (pre) and again 4 hours post-dosing (post) at approximately 1200 hours. During the group scan, the seven behaviors were recorded as seven one-letter codes. One would be entered for each 20-s period for each monkey. Thus, every 20 s, the observer had to write down one of seven codes for each of four monkeys. The number of intervals in which each behavior was observed was divided by the total number of 20-s scans×100, resulting in a percent of 20-s scans in which the behavior was observed (Altmann 1974) . Thus, a total of 30 samples of behavior, twice a day for 6 days (360 samples), were completed at each of five doses, for a total of 1, 800 samples of behavior. The specific aggressive behaviors recorded included open mouth threat, stare threat, chase, charge, lunge, and cage shake display, the frequency of which was summed for a total measure of aggression. The specific submissive behaviors recorded included submissive present, fear grimace, lip smack, move away, crouch, flee, scream, and scream threat, the frequency of which was summed for a total measure of submission. Locomotion was recorded if the monkey traversed space. Alone was recorded if the monkey was out of monkey arm's reach of another monkey. Social status was also determined weekly based on the direction of the outcome of agonistic interactions, not on frequencies of behaviors. Social status hierarchies were linear and stable over the course of the experiment. Operational definitions of all behaviors have been previously published (Shively et al. 1986 ). For analysis, weekly averages for the pre-dose and weekly averages for the post-dose time periods were calculated. Interobserver reliability was r ≥0.92.
Statistical analysis
The circulating levels of sertraline and desmethylsertraline and CSF metabolite concentrations were analyzed by oneway repeated measures analysis of variance (ANOVA). Initially, the behavioral data were analyzed by a 2 (dominant, subordinate)×2 (pre, post-dosing)×5 (doses) nested repeated measures ANOVA. ANOVA was also used for follow-up analyses of subsets of the data to clarify the effects found in the initial analyses. The significance level was set at p =0.05.
Results
Circulating levels of sertraline and desmethylsertraline and CSF levels of 5-HIAA Circadian variations in behavior are common. In general, active behaviors decline in the midday, and passive behaviors increase. Here, behavior was recorded daily before dosing (pre), at about 0800 hours, and 4 h later after the monkeys received their daily dose of sertraline, at about 1200 hours (post). Aggressive behavior was lower after dosing than before dosing (pre-post F [1,19] = 19.8, p < 0.0003), especially in dominant monkeys (social status×pre-post interaction: F [1,19] = 6.8, p < 0.02) (Fig. 1a) , and submissive behavior was lower after dosing than before dosing (pre-post F [1,19] = 15.6, p < 0.0009), especially in subordinate monkeys (social status×pre-post interaction: F [1,19] = 8.9, p < 0.008) (Fig. 1b) . As expected, locomotion (Fig. 1c) (Fig. 1a) . Submissive behavior also decreased with increasing dose of sertraline (dose F [4,76] = 4.6, p = 0.002), but only in subordinate monkeys (social status×dose interaction: F[4,76]=2.2, p < 0.02). Because of the circadian difference in submissive behavior reported above, a significant social status×dose× pre-post interaction (F [4,76]=2.6, p =0.04) was observed (Fig. 1b) . Further analysis comparing levels of submission pre-and post-dose at the 0-versus 20-mg dose using subordinate data only (2×2 ANOVA) revealed a significant main effect of dose (F[1,20] =5.7, p <0.03), confirming that sertraline reduced submissive behavior in subordinates.
Activity levels Locomotion decreased with increasing dose (dose F [4,76]=3.9, p <0.006) (Fig. 1c) .
Affiliation: grooming and being groomed Grooming (Fig. 2b) increased with increasing dose (dose F[4,76]=3.3, p <0.02); the dose effect on being groomed (Fig. 2a) was not significant. The dose×pre-post interaction was significant for grooming (F[4, 76] =3.2, p <0.02) and being groomed (F[4,76] =3.0, p =0.02). Visual inspection suggests that these interactions were due to the Fig. 1 Aggression, submission, and locomotion. The behavior units represent the percent of the scan observations in which the behavior was observed. a Aggressive behavior was higher in dominants than subordinates. Aggression was lower after dosing (post) than before dosing (pre) in dominant monkeys. Aggressive behavior decreased with increasing dose of sertraline in dominant monkeys. b Submissive behavior was higher in subordinates than dominants. Submissive behavior was lower after dosing (post) than before dosing (pre) in subordinates. Submissive behavior decreased with increasing dose of sertraline in subordinate monkeys. c Locomotion was lower after dosing (post) than before (pre) and decreased with increasing sertraline dose. SUB subordinate, DOM dominant, PRE prior to daily dosing, POST 4 h after daily dosing post-dose increase in grooming/being groomed at the 10-mg/kg dose (Fig. 2b) . The analysis was repeated without the 10-mg dose week, and a main effect of dose was observed on grooming (dose F[3,57]=3.1, p =0.03), but not on being groomed. Time alone (Fig. 2c) Sitting in passive body contact (Fig. 2d ) increased with increasing sertraline dose (dose F[4,76]=6.2, p =0.0002).
Discussion
Summary
In the study reported here, the administration of sertraline HCl had wide ranging effects on the social behavior of adult female nonhuman primates. The circulating concentrations of sertraline and desmethylsertraline demonstrate that the drug was successfully administered by training the animals for oral dosing. The circulating concentrations of sertraline and desmethylsertraline observed at the 20-mg/kg dose fell within the clinical range of efficacy observed in patients (Reis et al. 2004 ). The CSF concentration changes in 5-HIAA demonstrate that the sertraline reached the central nervous system and affected the 5-HT system. The observed decline in CSF 5-HIAA levels was of the approximate magnitude observed in prior studies of macaques (Anderson et al. 2005; Clarke et al. 1999) and is consistent with the 40-60 % declines typically seen in patients following sustained SSRI treatment (Sheline et al. 1997) . Thus, the observed decreases in agonistic behavior and increases in affiliative behavior with sertraline administration appear to be directly due to the drug.
It may be that SSRI efficacy in a range of human behavioral pathologies may be due, in part, to their specific beneficial effects on aggression and affiliation. The best recognized pathology affected by SSRIs is depression, which is often accompanied by anger, irritability, and aggression, as well as social isolation (Painuly et al. 2011) . To the extent that the observations made here are generalizable to human beings, it is possible that the antidepressant effects of SSRIs in patients may be due as much to their effects on agonism and affiliation as their effects on mood. There are some indications that SSRIs may be helpful in reducing aggression and increasing positive social behaviors in dementias and autism spectrum Fig. 2 Affiliation. The behavior units represent the percent of the scan observations in which the behavior was observed. a Being groomed: There was a significant dose by time of day interaction; however, subsequent analysis showed no significant effect of sertraline. b Grooming increased with increasing dose. c Alone:
The frequency in which the monkeys were observed alone was lower after (post) than before (pre) dosing. Time alone decreased with increasing dose of sertraline. d Sitting in passive body contact was higher after (post) than before (pre) dosing and increased with increasing dose of sertraline. PRE prior to daily dosing, POST 4 h after daily dosing disorder which support this hypothesis (Kolevzon et al. 2006; Pollock et al. 2007 ).
Design considerations
The purpose of this cumulative dose-response experiment was to document the effects of a commonly prescribed SSRI on broad aspects of primate social behavior. The cumulative doseresponse design has both strengths and weaknesses. The strengths are that the design mimics clinical care in that doses are typically adjusted without washout periods. Another major strength is that studies can be completed with smaller sample sizes in shorter time periods, both are critical concerns in nonhuman primate studies. The weaknesses are that data are only collected at each dose for 1 week and neurobiological effects of antidepressants continue to change over a period of several weeks; thus, the effects of dose and duration cannot be cleanly separated. However, many of the observed effects of sertraline involved increasing magnitude of change in behavior with increasing dose and time which is another indicator of a true effect of sertraline on behavior. The cumulative doseresponse design also does not include a placebo group which would provide an additional control and also facilitate blinding behavioral technicians to treatment.
Translational value of the model
The serotonergic system of macaques shares more similarities with human beings than rodent systems with regard to nuclear organization, projection pathways, innervation patterns, axonal morphologies, and 5-HT 1A receptor localization, making macaques the optimal models for investigations involving central nervous system 5-HT (Amaral and Lavenex 2007; Azmitia and Gannon 1986; Buckmaster and Amaral 2001) . The subjects were chosen to model the age-sex group of human beings that are prescribed the most antidepressants in the USA. The monkeys were also fed a diet modeled on a typical Western diet as macronutrient availability may alter neurobiological systems and because the usual laboratory monkey chow does not reflect either human consumption or feeding practices of monkeys in the wild and is replete with neurobiologically active isoflavones which alter 5-HT neurotransmission in macaques (Shively et al. 2003; Stroud et al. 2006 ).
Social modulation of pharmacological effects
A wealth of studies demonstrate the important effects of social factors, e.g., social support, social status, and social stress on depression. Because there is little information about the effects of SSRIs on socially housed primates and changes in aggression levels have been shown previously, we reasoned that in this initial study of socially housed monkeys, it was prudent to assign all animals in a social group to the same treatment (Higley et al. 1998; Carrillo et al. 2009; Yanowitch and Coccaro 2011) .
The effects on agonistic behavior were social statusdependent. Social status, determined by the outcomes of agonistic interactions and not the frequency, was stable throughout this experiment. Sertraline decreased aggressive behavior but only in dominants; subordinate aggressive behavior was already low and remained low throughout the study. Likewise, sertraline decreased submissive behavior but only in subordinates; submissive behavior of dominants was already low and remained so throughout the study. It is likely that the submissive behavior of subordinates decreased because the aggressive behavior of dominants decreased. This is an important consideration because when monkeys change social status from being subordinate to dominant, or vice versa, their agonist behavior follows and becomes appropriate for their social status. This suggests that the effects of sertraline, and perhaps other SSRIs, may be dependent on social variables and could change within a subject with changing social conditions. The fact that a social attribute of the monkeys, social status, modified the effects of sertraline on behavior suggests that studying the effects of pharmacologic agents in social-living subjects may better predict the range of effects that might be expected in human beings.
The role of serotonin Among their many neurobiological effects, SSRIs make more serotonin (5-HT) available in the synapse, altering central serotonergic neurotransmission. The observed decreases in CSF 5-HIAA following SSRI administration are presumed to be due to increased extracellular levels of 5-HT causing increased autoreceptor-mediated inhibitory feedback on synthesis/turnover of 5-HT. A wealth of preclinical and clinical data suggest that abnormally low serotonergic activity results in increased aggression (Carrillo et al. 2009; Moskowitz et al. 2003) . However, the majority of these studies necessarily rely either on cerebrospinal fluid concentrations of 5-HIAA or acute depletion of tryptophan, the percursor for 5-HT synthesis in the brain, and the interpretation of such studies is not straightforward. For example, CSF 5-HIAA concentrations reflect the sum of 5-HT metabolism in the CNS. CSF 5-HIAA may be low because 5-HT is low, which is how it is often interpreted, or it may be low because 5-HT metabolism is low leaving more 5-HT available at the site of action, as in the case of SSRI administration. Likewise, interpreting the neurobiological cause of behavioral responses to acute depletion of a neurotransmitter that modulates many neurotransmitter systems and processes in the brain is also fraught with difficulty. The sudden removal of function of such a ubiquitous modulator is bound to have overt acute effects that may be temporally bound. Increasing serotonin function in clinical populations appears to reduce aggression, and SSRIs are prescribed for aggressive disorders. However, whether increasing 5-HT decreases aggression in healthy individuals is less clear (Young 2013) . Likewise, while excessive aggression associated with low 5-HT is incompatible with friendly or affiliative behavior, it is also unclear whether raising 5-HT concentrations actually promote affiliation or just create a nonantagonistic situation that allows it (Young 2013) .
Circadian changes in social behavior
Observations were done daily just prior to and 4 h following sertraline dosing, at 0800 and 1200 h, respectively. The purpose was to capture potential differences in acute versus chronic changes in behavior and also to document the accumulation of effects which might begin to appear prior to daily dosing with the passage of time and increasing dose. However, circadian rhythms in behavior complicate the interpretation of the observations. In general, active behaviors (aggression, submission, locomotion) decline in the midday, and passive behaviors (sitting in body contact) increase as a normal part of circadian cycles in behavior. Here, main effects of time of day (i.e., pre-post) reflect consistent changes in behavior at every dose including baseline (0 mg sertraline). These are reasonably interpreted as circadian changes. However, change in behavior pre-versus post-dosing that was different at different doses required follow-up analyses to determine whether there was a true effect of sertraline on behavior. Follow-up analyses confirmed the effects of sertraline on submission (in subordinates only) and grooming, but not being groomed.
Unexpected variations in behavior after dosing
At 10-mg/kg dose, three unusual effects on behavior were observed after dosing: There was a sharp increase in time spent grooming, which was accompanied by a sharp increase in time spent being groomed, and decrease in time spent alone. Grooming is associated with reduced urinary cortisol metabolites in the groomer and reduced heart rate in the individual being groomed, suggesting that it reduces physiological stress responses (Shutt et al. 2007; Boccia et al. 1989 ). It may be that increased grooming by some of the monkeys was in response to a transient agitation which is often reported early in treatment in patients.
Summary and future research
Thus, sertraline, a commonly prescribed SSRI, has significant effects on spontaneous socioemotional behavior in female primates living in stable long-term social groups, decreasing agonism and increasing affiliation, two major axes of social behavior. The effects may well be amplified by all animals within a social group having the same treatment (sertraline or placebo). However, since SSRIs are among the most prescribed drugs in the USA, it is important to consider their global effects on behavior and social interaction in small groups such as families. The behavioral effects reported here reflect 5 weeks of exposure at gradually increasing doses until a dose corresponding to a therapeutic dose in human beings was reached. Since the majority of human beings who take antidepressants do so for more than 2 years, it will be important to determine the longer-term effects of commonly prescribed antidepressants on social interaction. Likewise, since a large proportion of antidepressant users are middleaged women, it will be important to study these long-term effects in women and female animal models.
